Lastly, we showed the identification of a glioma neoplastic cell marker, TRIB2, from single‐cell RNA‐seq data analysis, which could potentially become a drug target to tackle tumour heterogeneity challenges. Here, TRIB2 is linked to central nervous system cancer.